Saint Louis, France

Jan Kendall De Kruif

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Tillotts Pharma Ag. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Kendall De Kruif. Retrieved from https://idiyas.com/inventor/jan-kendall-de-kruif

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Kendall De Kruif: Innovator in Pharmaceutical Technology

Introduction

Jan Kendall De Kruif is a notable inventor based in Saint Louis, France. He has made significant contributions to the field of pharmaceutical technology, particularly through his innovative work on microgel particles.

Latest Patents

Jan Kendall De Kruif holds 1 patent for his invention titled "Microgel particles containing nanotubes loaded with an active pharmaceutical ingredient." This invention relates to microgel particles that incorporate nanotubes loaded with an active pharmaceutical ingredient, detailing a process for their preparation and a pharmaceutical composition that includes these particles.

Career Highlights

Jan is currently associated with Tillotts Pharma AG, where he applies his expertise in pharmaceutical development. His work focuses on enhancing drug delivery systems, which can significantly improve therapeutic outcomes.

Collaborations

Some of his notable coworkers include Carla Garofalo and Gisela Ledergerber, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Jan Kendall De Kruif's innovative work in pharmaceutical technology exemplifies the impact of research and development in improving healthcare solutions. His contributions continue to advance the field and inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…